DETAILED NOTES ON PSILOCYBIN EFFECTS ON NEURONS

The existing authors executed an open-label pilot study that administered psilocybin to 15 treatment-resistant tobacco/nicotine-dependent people who smoke, in the context of cognitive behavioral therapy for cigarette smoking cessation [58]. Members were being administered ~0.29 mg/kg oral psilocybin to the participant’s concentrate on day to quit